AHIP slams pharma for taking advantage of insurers

[Image omitted] - (http://www.fiercehealthpayer.com/story/ahip-slams-pharma-taking-advantage-insurers/2014-05-22) America's Health Insurance Plans has called out the drug industry for the soaring costs of new specialty medications (http://www.fiercehealthpayer.com/tags/specialty-drugs), saying such expensive pricing is unsustainable and takes unfair advantage of health insurers.

AHIP directed its censure at the Gilead Sciences hepatitis C drug Sovaldi, which costs $84,000 total and about $1,000 per pill, Reuters reported .

"Sovaldi has shown tremendous results, and it's the kind of medical innovation we need to sustain," the insurance lobby...